ATH alterity therapeutics limited

Ann: Alterity Presents Data Describing Neuroprotection of ATH434, page-15

  1. 136 Posts.
    lightbulb Created with Sketch. 53
    Yeah sure I don't disagree. 434 for FA would be in very different position to the Reata one, but as 434 would of shown its well tolerated in sick patients already, and ready for phase 2, it could still feed into the investment case somewhat. Cheers.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.1¢
Change
0.000(0.00%)
Mkt cap ! $100.4M
Open High Low Value Volume
1.0¢ 1.1¢ 1.0¢ $45.25K 4.114M

Buyers (Bids)

No. Vol. Price($)
31 11296464 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 7952306 5
View Market Depth
Last trade - 16.10pm 16/06/2025 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.